| |
| Issue |
Title |
| |
| No 4 (2014) |
Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia |
Abstract
PDF (Rus)
|
|
E. N. Tkhoseva, T. E. Morozova, O. A. Vartanova, S. M. Rykova, T. B. Andruschishina, D. A. Ermakov, S. M. Oshorova |
| |
| No 4 (2014) |
INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS? |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov |
| |
| No 4 (2014) |
Transformation of views on the teratogenic effects of antiepileptic drugs |
Abstract
PDF (Rus)
|
|
E. Yu. , R. N. Alyautdin, B. K. Romanov |
| |
| No 4 (2014) |
RETRACTED: Herpes Zoster in RA Patient treated with methotrexate |
Abstract
PDF (Rus)
|
|
Yu. V. Muraviev, G. I. Gridneva |
| |
| No 4 (2014) |
Good Pharmacovigilance Practice in the United States and the European Union |
Abstract
PDF (Rus)
|
|
V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev |
| |
| No 2 (2014) |
Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, В. К. Лепахин, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov |
| |
| No 2 (2014) |
Benefit-risk assessment of BCG vaccine in Russia: “Principle of three” method |
Abstract
PDF (Rus)
|
|
I. I. Snegiryova, K. E. Zatolochina, B. K. Romanov |
| |
| No 2 (2014) |
Qualitative methods of benefit / risk assessment |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov |
| |
| No 2 (2014) |
Medication errors |
Abstract
PDF (Rus)
|
|
B. K. Romanov, I. A. Toropova, E. Y. Kolesnikova |
| |
| No 2 (2014) |
Retrospective analysis of reports on psychopharmaceuticals drugs safety to identify cases of off-label |
Abstract
PDF (Rus)
|
|
E. O. Zhuravleva, V. A. Polivanov |
| |
| No 3 (2014) |
Dosis facit venenum |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin R.N, B. K. Romanov |
| |
| No 3 (2014) |
Monitoring of drug safety |
Abstract
PDF (Rus)
|
|
B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova |
| |
| No 3 (2014) |
ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, A. P. Pereverzev, B. K. Romanov, N. D. Bunyatyan |
| |
| No 3 (2014) |
ADVERSE DRUG REACTIONS IN CRIMEA REPUBLIC IN 2013 |
Abstract
PDF (Rus)
|
|
O. I. Koniaieva, O. V. Matvieiev |
| |
| No 3 (2014) |
PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS |
Abstract
PDF (Rus)
|
|
E. J. Kolesnikova |
| |
| No 3 (2014) |
USE OF DRUGS DURING THE FIRST TRIMESTER OF PREGNANCY IN TERMS OF FOETUS SAFETY: ANALYSIS OF PRESCRIBINGS |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov |
| |
| No 2 (2014) |
On the safety of acetaminophen |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, V. K. Lepakhin, B. K. Romanov, A. P. Pereverzev |
| |
| No 1 (2014) |
THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, V. K. Lepakhin, V. A. Merculov, N. A. Mironov |
| |
| No 1 (2014) |
LOCAL ANESTHETIC MYOTOXICITY |
Abstract
PDF (Rus)
|
|
B. K. Romanov, A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin |
| |
| No 1 (2014) |
INTERSTICIAL PNEUMONITIS, CAUSED BY PEGYLATED INTERFERON ALFA-2A IN A 4 MONTHS CHILD WITH GIGANTIC KAPOSI'S HAEMANGIOEPITHELIOM AND KASABACH – MERRIT PHENOMENON: A CASE REPORT |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, Yu. A. Polyaev, A. A. Mylnikov, A. N. Gricianskaya, M. N. Kostyleva, D. V. Rogogyn |
| |
| No 1 (2014) |
HERPES ZOSTER IN RA PATIENT TREATED WITH METHOTREXATE |
Abstract
PDF (Rus)
|
|
Yu. V. Muraviev, G. I. Gridneva |
| |
| No 2 (2015) |
THE SAFETY ASSESSMENT OF MEDICINAL PLANTS |
Abstract
PDF (Rus)
|
|
E. V. Shikh, V. M. Bulayev, O. A. Demidova |
| |
| No 2 (2016) |
Typical pharmacovigilance system master file (PSMF) |
Abstract
PDF (Rus)
|
|
B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov |
| |
| Vol 5, No 1 (2017) |
Rules of good laboratory practice: analysis of changes in the legislation |
Abstract
PDF (Rus)
|
|
N. Yu. Velts, T. M. Bukatina, E. Yu. Pasternak, T. N. Nikolaeva, S. V. Romanova |
| |
| No 2 (2015) |
RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL |
Abstract
PDF (Rus)
|
|
V. V. Arkhipov, N. G. Berdnikova, M. V. Zhuravleva, V. G. Kukes |
| |
| No 2 (2016) |
On improving the safety of new direct acting oral anticoagulants |
Abstract
PDF (Rus)
|
|
N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, T. M. Bukatina, O. E. Zhuravleva, R. N. Alyautdin, B. K. Romanov |
| |
| Vol 5, No 1 (2017) |
Modern approaches to collecting and reporting information on side effects |
Abstract
PDF (Rus)
|
|
K. E. Zatolochina, I. I. Snegireva, A. S. Kazakov, E. Yu. Kolesnikova, E. O. Zhuravleva, T. M. Bukatina, M. A. Darmostukova |
| |
| No 2 (2015) |
CHONDROTOXICITY OF FLUOROQUINOLONES IN CHILDREN: YES OR NO? |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, S. Y. Semykin, V. P. Nazhimov, A. I. Kamenev |
| |
| No 2 (2016) |
Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis |
Abstract
PDF (Rus)
|
|
T. M. Bukatina, A. S. Kazakov, N. Yu. Velts, M. A. Darmostukova, E. Yu. Kolesnikova, R. N. Alyautdin, B. K. Romanov |
| |
| Vol 5, No 1 (2017) |
Information on the decisions of foreign regulatory authorities |
Details
PDF (Rus)
|
|
T. M. Bukatina, E. Yu. Pasternak, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin, A. S. Kazakov, K. E. Zatolochina, I. I. Snegireva, M. A. Darmostukova, E. Yu. Kolesnikova, E. O. Zhuravleva, T. V. Romanova, N. Yu. Velts, M. L. Maximov, G. V. Kutekhova |
| |
| No 3 (2015) |
Identification and assessment of cases of malignant hyperthermia triggering under anaesthetic management: analysis of spontaneous reporting database |
Abstract
PDF (Rus)
|
|
E. Yu. Kolesnikova, E. O. Zhuravleva, I. L. Asetskaya, K. E. Zatolochina |
| |
| No 3 (2016) |
Guidelines for the planning and implementation of pharmacovigilance systems audit |
Abstract
PDF (Rus)
|
|
S. V. Glagolev, Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin |
| |
| Vol 5, No 2 (2017) |
Methodological approaches to the assessment of orphan medicinal products when making decisions about their inclusion in the program of medicinal maintenance: international experience and possible ways of its adaptation to the conditions of the health care system of the russian federation |
Abstract
PDF (Rus)
|
|
N. G. Goloenko, R. I. Yagudina, V. G. Serpik, A. Yu. Kulikov |
| |
| No 3 (2015) |
Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs |
Abstract
PDF (Rus)
|
|
E. O. Zhuravleva, E. Yu. Pasternak, K. E. Zatolochina |
| |
| No 3 (2016) |
Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results |
Abstract
PDF (Rus)
|
|
Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, S. V. Glagolev |
| |
| Vol 5, No 2 (2017) |
Analysis of spontaneous reports of adverse reactions, developed in the use of drugs during pregnancy |
Abstract
PDF (Rus)
|
|
E. O. Zhuravleva, N. Yu. Velts, K. E. Zatolochina, S. V. Glagolev, V. A. Polivanov, M. A. Darmostukova, V. K. Lepakhin, B. K. Romanov, R. N. Alyautdin |
| |
| No 3 (2015) |
The distribution of fullerene n anoparticles in the body in preclinical studies |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, V. A. Merkulov |
| |
| No 3 (2016) |
Physostigmine as an antinociceptive agent: a possible way to improve the safety of anesthesia |
Abstract
PDF (Rus)
|
|
A. . Nemirovsky |
| |
| Vol 5, No 2 (2017) |
Organic anion transporters and their influence on the toxicity of β-lactam antibiotics |
Abstract
PDF (Rus)
|
|
V. A. Evteev, O. V. Muslimova, I. A. Mazerkina, N. D. Bunyatyan, E. V. Shikh, R. E. Kazakov |
| |
| No 3 (2015) |
Monitoring post-approval drug safety in pregnancy: pharmacogenetic aspects |
Abstract
PDF (Rus)
|
|
|
| |
| No 3 (2016) |
Drug induced haematotoxicity |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, M. N. Kostylyova, A. N. Gratsianskaya, A. E. Ermilin |
| |
| Vol 5, No 2 (2017) |
Statistical signal detection methods |
Abstract
PDF (Rus)
|
|
K. E. Zatolochina, I. I. Snegireva, E. O. Zhuravleva, M. A. Darmostukova, R. N. Alyautdin |
| |
| No 4 (2015) |
A photosensitivity reaction to phenobarbital after taking ibuprofen |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, M. N. Kostileva, E. S. Ilina, T. A. Finogenova, M. A. Ostrovskaya |
| |
| No 3 (2016) |
Practical recommendations for screening of information on the drug safety |
Abstract
PDF (Rus)
|
|
E. Yu. Pasternak, T. M. Bukatina, R. N. Alyautdin, B. K. Romanov |
| |
| Vol 5, No 4 (2017) |
Standard form of a periodic safety update report |
Abstract
PDF (Rus)
|
|
B. R. Romanov, R. N. Alyautdin, M. A. Darmostukova, S. V. Glagolev, V. A. Polivanov |
| |
| No 4 (2015) |
Recommendations for evaluating the safety of medicinal products containing nanoparticles |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov |
| |
| No 4 (2016) |
«Propofol infusion syndrome» - case in a child of 10 years |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, M. N. Kostyleva, G. P. Bryusov |
| |
| Vol 5, No 4 (2017) |
Problems of interchangeability of systemic interferons for treatment of multiple sclerosis |
Abstract
PDF (Rus)
|
|
I. I. Snegireva, E. Yu. Pasternak, K. E. Zatolochina, M. A. Darmostukova, R. N. Alyautdin, V. A. Polivanov |
| |
| No 1 (2015) |
RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov |
| |
| No 4 (2015) |
Checking and correction of drug information in the standards of care and clinical guidelines |
Abstract
PDF (Rus)
|
|
B. K. Romanov |
| |
| 1 - 50 of 72 Items |
1 2 > >>
|
